White Biotech Market Report | Market Size, Industry Analysis, Growth Opportunities, & Forecast (2025-2030)

White Biotech Market – Overview

The White Biotech Market, also known as industrial biotechnology, is witnessing significant growth due to its potential to deliver sustainable and eco-friendly alternatives across various industries. This segment of biotechnology focuses on using living cells and enzymes to produce industrial products such as biofuels, bioplastics, biochemicals, and enzymes. The demand for greener manufacturing processes, reduced dependency on fossil fuels, and rising environmental regulations are key drivers propelling the growth of white biotechnology.

Industries such as chemicals, textiles, paper, food & beverages, and pharmaceuticals are increasingly adopting white biotech solutions to improve process efficiency and reduce carbon footprints. Moreover, the growing emphasis on the circular economy and waste valorization is further boosting the market’s relevance. Technological advancements in genetic engineering, synthetic biology, and fermentation are enabling the development of innovative bio-based products with commercial viability.

As governments worldwide enforce stricter sustainability goals and carbon neutrality targets, the white biotech market is poised for robust expansion, especially in regions like Europe, North America, and Asia-Pacific.

Market Report Coverage:

The “White Biotech Market Report—Future (2025-2030)” by Digiroads Research & Consulting covers an in-depth analysis of the following segments in the market.

Study Assumptions and Definitions

The White Biotech Market study is based on extensive secondary and primary research. It assumes that market growth will be driven by increasing industrial sustainability goals, advancements in biotechnology, and expanding applications across diverse end-use industries. Data is projected from historical performance, current trends, and forecasted scenarios from 2024 through 2032.

Key assumptions include a steady global regulatory shift towards bio-based and low-emission industrial processes, growing R&D investments in synthetic biology and metabolic engineering, and rising global awareness of climate change mitigation. Additionally, it presumes continued governmental and institutional support in the form of subsidies, tax breaks, and environmental policy mandates to encourage the adoption of white biotech solutions.

Definitions:

• White Biotechnology refers to the use of biological systems and organisms to produce chemicals, materials, and energy in an industrial context, reducing environmental impact.
• Biofuels: Renewable fuels derived from biological sources.
• Bioplastics: Plastics derived from renewable biomass sources.
• Industrial Enzymes: Enzymes used in industrial applications for catalyzing biochemical reactions.

These definitions frame the scope and metrics used throughout the study to analyze market dynamics, estimate market size, and understand trends across geographies and applications.

Market Scope

This report provides a comprehensive analysis of the White Biotech Market, focusing on its development across key industrial sectors globally. It includes detailed market size estimation, growth forecasts, and in-depth segmentation based on product types, applications, organism types, technologies, and regions. The study evaluates market trends, opportunities, and challenges, offering insights into how white biotech is transforming industrial practices toward sustainability.

The scope covers major bio-based products including biofuels, bioplastics, biochemicals, and industrial enzymes, along with their applications in food and beverages, chemicals, pharmaceuticals, and textiles. Technological insights such as fermentation, enzyme engineering, and synthetic biology are also included.

Geographically, the report segments the market into North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa, highlighting regional demand trends, regulatory environments, and growth opportunities. Stakeholders can leverage this report for strategic decision-making, investment planning, and competitive analysis in the evolving bioeconomy landscape.

MARKET OUTLOOK

Executive Summary

The White Biotech Market is undergoing rapid transformation, driven by the global shift toward sustainable industrial practices. Often referred to as industrial biotechnology, white biotech utilizes living organisms and enzymes to produce bio-based products such as biofuels, bioplastics, biochemicals, and industrial enzymes. This sector is gaining significant traction as industries seek alternatives to traditional fossil-based manufacturing to reduce emissions and environmental impact.

Governments and regulatory bodies worldwide are enforcing policies that favor bio-based production, including tax incentives and emissions reduction targets. These factors, coupled with rising environmental awareness and corporate sustainability goals, are creating a fertile ground for white biotech expansion. Technological innovations in synthetic biology, metabolic engineering, and enzyme design are further enhancing the efficiency and scalability of bio-based manufacturing.

Among the most prominent applications, the chemical and pharmaceutical industries are adopting white biotech technologies to streamline production and minimize waste. Similarly, sectors such as textiles, pulp & paper, and food & beverages are integrating industrial biotechnology to improve product performance and sustainability.

North America and Europe currently dominate the market due to their strong regulatory frameworks and R&D infrastructure. However, Asia-Pacific is emerging as a key growth region, propelled by increasing industrialization, environmental initiatives, and rising demand for sustainable alternatives in major economies such as China and India.

Key market players such as Cargill, BASF, DSM, and Novozymes are actively investing in R&D and partnerships to develop innovative, market-ready bio-based products. The competitive landscape is also witnessing the entry of startups and niche players that are introducing disruptive technologies.

In summary, the White Biotech Market is positioned as a crucial pillar of the future bioeconomy, with significant opportunities for innovation, investment, and sustainable industrial development across the globe.

COMPETITIVE LANDSCAPE

Key Market Players

• BASF SE
• Cargill, Incorporated
• DuPont de Nemours, Inc.
• Novozymes A/S
• Koninklijke DSM N.V.
• Archer Daniels Midland Company (ADM)
• Evonik Industries AG
• Clariant AG
• Lonza Group Ltd
• Genomatica Inc.
• Amyris Inc.
• BioAmber Inc.
• Codexis Inc.
• Solvay SA
• Ginkgo Bioworks

Market Share Analysis

The White Biotech Market is characterized by the presence of several global players with diversified portfolios and strong R&D capabilities. Major players such as BASF, Novozymes, and DSM hold significant market shares, benefiting from early adoption, broad application scopes, and robust bio-manufacturing infrastructure. These companies account for a substantial portion of revenue in segments like industrial enzymes and biochemicals, driven by long-standing partnerships across end-use industries.

Novozymes leads the enzyme production segment, supplying tailored solutions to the textile, food, and biofuel sectors. DSM and BASF dominate the biochemicals segment, leveraging integrated supply chains and strategic acquisitions. ADM and Cargill, with strong global reach, focus on biofuel and agricultural biotech innovations, positioning themselves strongly in North America and Europe.

Emerging companies like Amyris and Genomatica are disrupting traditional markets by leveraging synthetic biology to produce sustainable alternatives to petroleum-derived products. Their agile innovation models and partnerships with global brands give them a competitive edge in niche segments.

Asia-Pacific is showing increased market activity, led by regional firms and collaborations focused on cost-effective, scalable white biotech solutions. The market remains moderately consolidated, with top-tier players controlling more than 50% of the revenue, while SMEs and startups contribute through specialized innovations and regional expansions.

MARKET DYNAMICS

Market Drivers and Key Innovations

1. Sustainability Demands: Growing focus on reducing industrial carbon footprints is accelerating the shift to bio-based alternatives.
2. Supportive Regulations: Policies promoting green manufacturing, including carbon taxes and biofuel mandates, are driving adoption.
3. Consumer Awareness: Rising demand for eco-friendly and non-toxic products is fueling market expansion across industries.
4. Technological Advancements: Developments in fermentation, enzyme engineering, and synthetic biology are enabling efficient and scalable production.

Key Innovations:

• CRISPR and Gene Editing Tools: Used for developing highly efficient microbial strains to produce enzymes and bio-products.
• Metabolic Engineering: Tailoring microbial metabolism for enhanced yield and product specificity.
• Enzyme Cascade Systems: Innovations in multi-step enzymatic reactions have streamlined complex biochemical production.
• Bioreactor Design: Smart bioreactors with AI integration are improving process control, yield, and scalability.

Market Challenges

1. High Production Costs: Despite long-term cost benefits, the initial investment and operating costs for white biotech production remain high. Infrastructure setup, R&D, and fermentation-based processing are capital-intensive, limiting adoption for small manufacturers.
2. Scale-Up Limitations: Transitioning from lab-scale to industrial-scale production remains a key hurdle. Maintaining consistent yields and quality at commercial volumes can be technologically and financially challenging.
3. Limited Awareness in Developing Economies: Lack of understanding about the long-term environmental and economic benefits of white biotech solutions in emerging markets hinders market penetration.
4. Feedstock Availability and Pricing Volatility: Dependence on agricultural biomass and other organic feedstocks creates risks related to seasonal availability and price fluctuations, impacting cost efficiency.
5. Regulatory Complexities: Although supportive in some regions, bio-manufacturing is subject to varied and often complex regulatory frameworks globally. This inconsistency slows down approvals, increases compliance costs, and deters international collaboration.
6. Competition from Petrochemical Alternatives: Despite sustainability trends, conventional petrochemical-based products often remain cheaper and more established, creating strong competition in cost-sensitive markets.
7. Technical Bottlenecks: Bioprocesses like fermentation are sensitive to contamination and require precise control, which increases operational risks and costs.

Market Opportunities

1. Expansion in Asia-Pacific Markets: Emerging economies like India and China offer untapped potential due to rapid industrialization and increasing focus on sustainable solutions.
2. Biofuel Mandates: Governments promoting biofuels as part of energy transition plans create vast opportunities for bioethanol and biodiesel production.
3. Bioplastics Demand: Rising bans on single-use plastics and demand for biodegradable alternatives offer strong growth potential for bio-based polymers.
4. Pharmaceutical Applications: Industrial enzymes and microbial fermentation are increasingly used in antibiotic, vaccine, and therapeutic manufacturing.
5. Agro-Biotech Integration: Bio-based pesticides, fertilizers, and soil enhancers represent an emerging opportunity in sustainable agriculture.
6. Synthetic Biology Startups: Rising VC investment in synthetic biology is fostering the growth of new market entrants focused on niche biotech applications.
7. Circular Economy Models: Companies adopting waste-to-resource models using biotech processes are creating scalable, profitable, and eco-friendly solutions.
8. Smart Bioprocessing Technologies: Integration of AI, IoT, and automation in bioprocesses improves yields and reduces cost, unlocking commercial viability.

RECENT STRATEGIES & DEVELOPMENTS IN THE MARKET

1. Novozymes and Chr. Hansen Merger (2023): This €12.3 billion merger aims to create a global leader in biosolutions, enhancing enzyme and fermentation capabilities.
2. DSM Acquires First Choice Ingredients (2022): Strengthens DSM’s presence in bio-based flavor and functional ingredient production.
3. BASF Partners with Biomillenia (2023): Collaboration focuses on microbiome-based product development using high-throughput screening technologies.
4. Genomatica Expands Partnership with Lululemon (2022): Focuses on bio-nylon production for sustainable apparel, signaling entry into the textile sector with biotech innovations.
5. Amyris Launches Bio-Based Squalane Products (2023): Expands its personal care portfolio through sustainable skincare ingredients.
6. Evonik Invests in Bio-Based Surfactants Facility in Slovakia (2023): Aims to meet increasing demand in the home care and personal care industry with eco-friendly formulations.
7. Clariant Develops Cellulosic Ethanol Plant in Romania (2022): Demonstrates commercial viability of second-generation biofuels using agricultural residues.

KEY BENEFITS FOR STAKEHOLDERS

1. Manufacturers: Access to cost-efficient, scalable, and sustainable production methods with reduced dependence on fossil fuels.
2. Investors: Growing market potential in line with global sustainability and ESG trends makes it an attractive investment sector.
3. Governments: White biotech supports national goals for carbon reduction, energy independence, and sustainable industrial development.
4. Consumers: Availability of cleaner, safer, and eco-friendly alternatives in everyday products.
5. Startups: Opportunities to innovate and disrupt traditional industrial processes with niche biotech solutions.
6. Academia & Researchers: Scope for interdisciplinary research in synthetic biology, enzyme engineering, and industrial chemistry.
7. Environmental Groups: Alignment with biodiversity conservation and waste management goals through green manufacturing practices.
8. Supply Chain Stakeholders: Improved traceability, resource efficiency, and product quality throughout the bio-based value chain.

At DigiRoads Research, we emphasize reliability by employing robust market estimation and data validation methodologies. Our insights are further enhanced by our proprietary data forecasting model, which projects market growth trends up to 2030. This forward-thinking approach ensures our analysis not only captures the current market landscape but also anticipates future developments, equipping stakeholders with actionable foresight.

We go a step further by offering an exhaustive set of regional and country-level data points, supplemented by over 60 detailed charts at no additional cost. This commitment to transparency and accessibility allows stakeholders to gain a deep understanding of the industry’s structural and operational dynamics. By providing exclusive and hard-to-access data, DigiRoads Research empowers businesses to make informed strategic decisions with confidence.

In essence, our methodology and data delivery foster a collaborative and data-driven decision-making environment, enabling businesses to navigate industry challenges and capitalize on opportunities effectively.

Contact Us For More Inquiry. 

Table of Contents

• INTRODUCTION

  • Market Overview
  • Years Considered for Study
  • Market Segmentation
  • Study Assumptions and Definitions
  • Market Scope

• RESEARCH METHODOLOGY

• MARKET OUTLOOK

  • Executive Summary
  • Market Snapshot
• Market Segments 
  • By Product:
    • Biofuels, Biochemicals, Bioplastics, Industrial Enzymes
  • By Organism Type:
    • Microorganisms, Yeast, Fungi, Others

• COMPETITIVE LANDSCAPE

• Recent Strategies (Key Strategic Moves)
• Market Share Analysis
• Company Profiles
  • BASF SE
  • Cargill, Incorporated
  • DuPont de Nemours, Inc.
  • Novozymes A/S
  • Koninklijke DSM N.V.
  • Archer Daniels Midland Company (ADM)
  • Evonik Industries AG
  • Clariant AG
  • Lonza Group Ltd
  • Genomatica Inc.
  • Amyris Inc.
  • BioAmber Inc.
  • Codexis Inc.
  • Solvay SA
  • Ginkgo Bioworks

• MARKET DYNAMICS

  • Market Drivers
  • Market Challenges
  • Market Opportunities
  • Porter’s Five Forces’ Analysis
    • Bargaining Power of Suppliers
    • Bargaining Power of Buyers
    • Threat of New Entrant
    • Threat of Substitutes
    • Competitive Rivalry

• GLOSSARY OF PROMINENT SECONDARY SOURCES

• DISCLAIMER

• ABOUT US